Clinical trials
Phase 1 Diabetes Mellitus trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 3 |
| 2012 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 4 |
| 2021 | 2 |
| 2022 | 6 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 5 |
| 2026 | 5 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 29 |
| Unknown status | 7 |
| Active, not recruiting | 4 |
| Recruiting | 4 |
| Not yet recruiting | 2 |
| Withdrawn | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Jiangsu HengRui Medicine Co., Ltd. | 7 |
| Novo Nordisk A/S | 7 |
| Gan and Lee Pharmaceuticals, USA | 3 |
| Cellonis Biotechnology Co. Ltd. | 2 |
| Hangzhou Reprogenix Bioscience, Inc | 2 |
| Merck KGaA, Darmstadt, Germany | 2 |
| Shandong Suncadia Medicine Co., Ltd. | 2 |
| Shanghai Zhongshan Hospital | 2 |
| Suzhou Yabao Pharmaceutical R&D Co., Ltd. | 2 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus | 49 |
| Diabetes Mellitus, Type 2 | 7 |
| Obesity | 3 |
| Atherosclerosis | 2 |
| Diabetes Mellitus, Type 1 | 2 |
| Overweight | 2 |
| Diabetic Neuropathies | 1 |
| Hyperglycemia | 1 |
| Inflammation | 1 |
| Kidney Failure, Chronic | 1 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.